Show simple item record

dc.contributor.authorKarch, André
dc.contributor.authorHermann, Peter
dc.contributor.authorPonto, Claudia
dc.contributor.authorSchmitz, Matthias
dc.contributor.authorArora, Amandeep
dc.contributor.authorZafar, Saima
dc.contributor.authorLlorens, Franc
dc.contributor.authorMüller-Heine, Annika
dc.contributor.authorZerr, Inga
dc.date.accessioned2015-09-14T13:58:08Zen
dc.date.available2015-09-14T13:58:08Zen
dc.date.issued2015-05en
dc.identifier.citationCerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease. 2015, 36 (5):1964-8 Neurobiol. Agingen
dc.identifier.issn1558-1497en
dc.identifier.pmid25749129en
dc.identifier.doi10.1016/j.neurobiolaging.2015.01.021en
dc.identifier.urihttp://hdl.handle.net/10033/577242en
dc.description.abstractThe molecular subtype of sporadic Creutzfeldt-Jakob disease (sCJD) is an important prognostic marker for patient survival. However, subtype determination is not possible during lifetime. Because the rate of disease progression is associated with the molecular subtype, this study aimed at investigating if total tau, a marker of neuronal death, allows premortem diagnosis of molecular subtype when codon 129 genotype is known. Two hundred ninety-six sCJD patients were tested for their cerebrospinal fluid total tau level at the time of diagnosis and were investigated for their sCJD subtype postmortem. There was a significant association between tau levels and the prion protein type in patients with codon 129 MM (p < 0.001), MV (p = 0.004), and VV (p = 0.001) genotype. Receiver operating characteristic analyses showed values of area under the curve of 0.76-0.80 for the different genotypes indicating a good diagnostic validity of the test. Total tau can be used as a diagnostic test for the assessment of prion protein type when codon 129 genotype is known. It provides valuable information for physicians and next of kin about the further course of disease.
dc.language.isoenen
dc.titleCerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.en
dc.typeArticleen
dc.contributor.departmentHelmholtz Centre for infection research, Inhoffenstr. 7, D-38124 Braunschweig, Germany.en
dc.identifier.journalNeurobiology of agingen
refterms.dateFOA2016-05-15T00:00:00Z
html.description.abstractThe molecular subtype of sporadic Creutzfeldt-Jakob disease (sCJD) is an important prognostic marker for patient survival. However, subtype determination is not possible during lifetime. Because the rate of disease progression is associated with the molecular subtype, this study aimed at investigating if total tau, a marker of neuronal death, allows premortem diagnosis of molecular subtype when codon 129 genotype is known. Two hundred ninety-six sCJD patients were tested for their cerebrospinal fluid total tau level at the time of diagnosis and were investigated for their sCJD subtype postmortem. There was a significant association between tau levels and the prion protein type in patients with codon 129 MM (p < 0.001), MV (p = 0.004), and VV (p = 0.001) genotype. Receiver operating characteristic analyses showed values of area under the curve of 0.76-0.80 for the different genotypes indicating a good diagnostic validity of the test. Total tau can be used as a diagnostic test for the assessment of prion protein type when codon 129 genotype is known. It provides valuable information for physicians and next of kin about the further course of disease.


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
Karch et al_final.pdf
Size:
215.9Kb
Format:
PDF
Description:
original manuscript
Thumbnail
Name:
Figure 1.tiff
Size:
457.8Kb
Format:
TIFF image
Description:
figure 1
Thumbnail
Name:
Figure 2.tiff
Size:
263.6Kb
Format:
TIFF image
Description:
figure 2

This item appears in the following Collection(s)

Show simple item record